Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2016 1
2017 1
2020 5
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data.
Delhomme TM, Avogbe PH, Gabriel AAG, Alcala N, Leblay N, Voegele C, Vallée M, Chopard P, Chabrier A, Abedi-Ardekani B, Gaborieau V, Holcatova I, Janout V, Foretová L, Milosavljevic S, Zaridze D, Mukeriya A, Brambilla E, Brennan P, Scelo G, Fernandez-Cuesta L, Byrnes G, Calvez-Kelm FL, McKay JD, Foll M. Delhomme TM, et al. Among authors: calvez kelm fl. NAR Genom Bioinform. 2020 Jun;2(2):lqaa021. doi: 10.1093/nargab/lqaa021. Epub 2020 Apr 20. NAR Genom Bioinform. 2020. PMID: 32363341 Free PMC article.
Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study.
Singleton RK, Heath AK, Clasen JL, Scelo G, Johansson M, Calvez-Kelm FL, Weiderpass E, Liedberg F, Ljungberg B, Harbs J, Olsen A, Tjønneland A, Dahm CC, Kaaks R, Fortner RT, Panico S, Tagliabue G, Masala G, Tumino R, Ricceri F, Gram IT, Santiuste C, Bonet C, Rodriguez-Barranco M, Schulze MB, Bergmann MM, Travis RC, Tzoulaki I, Riboli E, Muller DC. Singleton RK, et al. Among authors: calvez kelm fl. Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):507-512. doi: 10.1158/1055-9965.EPI-20-1438. Epub 2020 Dec 17. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33335022
Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer.
Hosen MI, Forey N, Durand G, Voegele C, Bilici S, Avogbe PH, Delhomme TM, Foll M, Manel A, Vian E, Meziani S, De Tilly B, Polo G, Lole O, Francois P, Boureille A, Pisarev E, Salas AROSE, Monteiro-Reis S, Henrique R, Byrnes G, Jeronimo C, Scelo G, McKay JD, Calvez-Kelm FL, Zvereva M. Hosen MI, et al. Among authors: calvez kelm fl. Cancers (Basel). 2020 Nov 27;12(12):3541. doi: 10.3390/cancers12123541. Cancers (Basel). 2020. PMID: 33260905 Free PMC article.
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.
Hosen MI, Sheikh M, Zvereva M, Scelo G, Forey N, Durand G, Voegele C, Poustchi H, Khoshnia M, Roshandel G, Sotoudeh M, Nikmanesh A, Etemadi A, Avogbe PH, Chopard P, Delhomme TM, Foll M, Manel A, Vian E, Weiderpass E, Kamangar F, Boffetta P, Pharaoh PD, Dawsey SM, Abnet CC, Brennan P, McKay J, Malekzadeh R, Calvez-Kelm FL. Hosen MI, et al. Among authors: calvez kelm fl. EBioMedicine. 2020 Mar;53:102643. doi: 10.1016/j.ebiom.2020.102643. Epub 2020 Feb 17. EBioMedicine. 2020. PMID: 32081602 Free PMC article.
Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches.
Perdomo S, Avogbe PH, Foll M, Abedi-Ardekani B, Facciolla VL, Anantharaman D, Chopard P, Calvez-Kelm FL, Vilensky M, Polesel J, Holcatova I, Simonato L, Canova C, Lagiou P, McKay JD, Brennan P. Perdomo S, et al. Among authors: calvez kelm fl. Oncotarget. 2017 Aug 7;8(42):72621-72632. doi: 10.18632/oncotarget.20004. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069814 Free PMC article.
Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis.
Nguyen-Dumont T, Calvez-Kelm FL, Forey N, McKay-Chopin S, Garritano S, Gioia-Patricola L, De Silva D, Weigel R, Sangrajrang S, Lesueur F, Tavtigian SV; Breast Cancer Family Registries (BCFR); Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Nguyen-Dumont T, et al. Among authors: calvez kelm fl. Hum Mutat. 2009 Jun;30(6):884-90. doi: 10.1002/humu.20949. Hum Mutat. 2009. PMID: 19347964 Free PMC article.
Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.
Palmero EI, Alemar B, Schüler-Faccini L, Hainaut P, Moreira-Filho CA, Ewald IP, Santos PK, Ribeiro PL, Oliveira CB, Calvez-Kelm FL, Tavtigian S, Cossio SL, Giugliani R, Caleffi M, Ashton-Prolla P. Palmero EI, et al. Among authors: calvez kelm fl. Genet Mol Biol. 2016 May 24;39(2):210-22. doi: 10.1590/1678-4685-GMB-2014-0363. Genet Mol Biol. 2016. PMID: 27223485 Free PMC article.